FSHR and ovarian neoplasm: Evaluation of different FSHR-expressing ovarian tumor cells demonstrated that D2AP11-TCE was highly efficient in the killing of CAOV3 (Figure 7, F and G), OVCAR3-FSHR (Figure 7, H and I, and Supplemental Figure 3A), OVCAR4 (Figure 7J and Supplemental Figure 3, B and C), OVISE (Figure 7, K and L), PEO-4 (Figure 7M), and Kuramochi-FSHR cells (Figure 7N).